Florida's First and Newest Implant to Treat Heart Failure & Sudden Cardiac Death
March 01, 2012
Kissimmee, FL – Central Florida Cardiac & Vascular Institute of Osceola Regional Medical Center announced one of Central Florida’s first and newest Boston Scientific defibrillator implanted on February, 17, 2012. The implant of the next generation of the implantable cardioverter defibrillator (ICD) was performed by Naushad Shaik, MD, Cardiologist and Electrophysiologist affiliated with Osceola Regional Medical Center and its Cardiac & Vascular Institute. This will also be one of the first in HCA hospitals to implant this new Boston Scientific device.
The ENERGEN DF-4 device is one of the latest Boston Scientific FDA approved collection of high-energy and smallest devices to treat heart failure and sudden cardiac death. Central Florida patients and physicians can now benefit from its enhanced therapy options, advanced battery longevity with a back up warranty of 10 years and a DF4 universal connector system in the industry’s smallest and thinnest platform.
“Creating longer-lasting devices is simply the right thing to do for the patients,” said Naushad Shaik, MD. “It benefits those who are living longer due to advances in device therapy, those who are receiving devices earlier in their lives based on our clinical science and those who need more frequent device changes because of their clinical condition.”
Electrophysiology (EP) is a subspecialty of cardiology and examines the electrical behavior of the heart. At Central Florida Cardiac & Vascular Institute, the EP lab is the first of its kind in Osceola County, and is staffed by experts who are highly trained in diagnosing and treating irregular heartbeats (also known as arrhythmias). Our hospital is on the cutting edge of cardiovascular care, and it boasts a revolutionary Carto® 3 Navigation System. This incredible technology allows an Electrophysiologist to review a map of a patient’s heart and monitor its electrical activity in 3D and in real time. This heart map helps determine the origin of the arrhythmia and assists the physician in guiding a catheter to the right place to treat the problem. The Institute specializes in Ablation studies, Lead management systems, Atrial fibrillation management, Pacemaker insertion and monitoring, Implantable defibrillators and Implantable cardioverter defibrillators.
Marketing & Public Relations Contact: